FORM 5 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Form 3 Holdings Reported Form 4 Transactions Reported

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0362 Expires: January 31, 2005 Estimated average burden hours per response... 1.0

1. Name and Address of Reporting Person * WEIL JOHN D 2. Issuer Name and Ticker or Trading Symbol ALLIED HEALTHCARE PRODUCTS INC [AHPI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 200 N BROADWAY SUITE 825 3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year) 12/31/2011 (Street) ST LOUIS, MO 63102 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Reporting (check applicable line) _X_ Form Filed by One Reporting Person ___ Form Filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Amount (A) or (D) Price Common Stock             4,000 I IRA (1) Common Stock             40,074 D   Common Stock             188,855 (1) I Spouse Common Stock             118,203 I Trust (2) Common Stock             447,361 I Trust (3) Common Stock             990,079 I Limited Partnership (4) Common Stock             15,853 I Corporation (5) Common Stock 12/31/2011   J(7) 13,421 A $ (7) 239,587 (8) I Trust (6)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

SEC 2270 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
WEIL JOHN D 200 N BROADWAY SUITE 825 ST LOUIS, MO 63102	  X	  X	Â	Â

Signatures

John D. Weil		12/20/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The reporting person disclaims any economic benefit in such shares.
(2)	Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee.
(3)	Owned by a trust for the benefit of a sibling of the reporting person and for which the reporting person acts as co-trustee. The reporting person disclaims any economic benefit in such shares.
(4)	Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B).
(5)	Owned by a corporation controlled by the reporting person.
(6)	Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person and/or members of his immediate family have a contingent remainder interest. The reporting person disclaims any economic benefit in such shares.
(7)	Shares acquired in a transfer for no consideration among the reporting person and members of the reporting person's family, including shares transferred in connection with a liquidation of a family limited partnership. Reporting person timely reported the disposition of these shares from a family limited partnership on a Form 4 filed on January 16, 2012. Reporting person inadvertently failed to report that the shares were transferred to the trusts described in Note 6, as his pecuniary interest results only from contingent remainder interests in the trusts held by certain members of his immediate family who do not share his household.
(8)	Total reported shares held by these trusts as of December 31, 2011 includes results of transactions reported late on a Form 4/A filed November 15, 2013.

Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.